Rehab Centers in PA Free Rehabs in PA Rehab Centers in PA

Rehab Centers in PA Free Rehabs in PA Rehab Centers in PA

Advaxis, Inc. (ADXS): Compelling Phase II Data De-risks Advaxis
All patients randomized to the trial have been previously treated with chemotherapy, radiotherapy or both, and their cancer has progressed subsequent to treatment and has been confirmed by CT or radiologic scan. …. ADXS-HPV is granted orphan drug … Read more on Seeking Alpha

Auxilium Pharmaceuticals Presented New Analyses of XIAFLEX(R) Peyronie's …
The Company's supplemental Biologics License Application (sBLA) for XIAFLEX, for the treatment of PD is currently under review at the Food and Drug Administration (FDA). The Prescription Drug User Fee Act (PDUFA) review date is December 6, 2013. Read more on Wall Street Journal